ESC Guidelines 2389 disclosure forms are kept on file at the European Heart House,
headquarters of the ESC. Any changes in conflict of interest that arise during the writing …

Life expectancy and quality of life for those born with congenital heart disease (CHD) have
greatly improved over the past 3 decades. While representing a great advance for these …

The content of these European Society of Cardiology (ESC) Guidelines has been published
for personal and educational use only. No commercial use is authorized. No part of the ESC …

Aims Mortality in adults with congenital heart disease is known to be increased, yet its extent
and the major mortality risks are unclear. Methods and results The Dutch CONCOR national …

Background—Sudden cardiac death (SCD) is a major cause of mortality in adults with
congenital heart disease (CHD). The aim of this study was to determine the adult CHD …

Aims This study compared the clinical, functional, and haemodynamic characteristics and
current era survival of subgroups of patients with pulmonary arterial hypertension associated …

Background—Advanced therapy (AT) for pulmonary arterial hypertension in the context of
congenital heart disease (Eisenmenger syndrome) improves pulmonary hemodynamics …

Pulmonary arterial hypertension of variable degree is commonly associated with adult
congenital heart disease. Depending on size and location of the underlying cardiac defect …

Pulmonary arterial hypertension (PAH) is a common complication of congenital heart
disease (CHD), with most cases occurring in patients with congenital cardiac shunts. In …

Objectives: The study sought to measure the prevalence, disease burden, and determinants
of mortality in geriatric adults with congenital heart disease (ACHD). Background: The …